Catalog Number UNK HIP FEMORAL HEAD |
Device Problem
Appropriate Term/Code Not Available (3191)
|
Patient Problems
Fever (1858); Foreign Body Reaction (1868); Unspecified Infection (1930); Pain (1994)
|
Event Date 12/05/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.No 510# number provided because this implant is sold internationally with different indications for use; it is currently sold in the us under a different part number.The correction/removal reporting number listed applies to the corresponding product code sold domestically.
|
|
Event Description
|
Translated asr claim letter received.Litigation alleges pain, high body temperature, infection, presence of chromium and cobalt which generated actual metallosis, which causing poisoning as well as organ damage.It was also indicated that there was walking and hip abductions problems.Doi: (b)(6) 2008; dor: not reported; right hip.
|
|
Manufacturer Narrative
|
Product complaint #(b)(4).Investigation summary: the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa (b)(4).Ongoing post market surveillance is conducted per our procedures for this product.Device history lot: null; device history lot: null; device history review: null.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
(b)(4).Investigation summary: the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa-(b)(4).Ongoing post market surveillance is conducted per our procedures for this product.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|